Literature DB >> 7780059

Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency.

R A Ward1, K R McLeish.   

Abstract

Previous reports that polymorphonuclear leukocyte (PMN) function is impaired in hemodialysis patients do not differentiate between effects of dialysis and of uremia. The hypothesis that chronic renal insufficiency impairs PMN function was tested. Phagocytosis and oxidative burst were measured in PMN from patients with varying degrees of chronic renal insufficiency impairs PMN function was tested. Phagocytosis and oxidative burst were measured in PMN from patients with varying degrees of chronic renal insufficiency (creatinine clearance, 6 to 35 mL/min per 1.73 m2) and normal subjects. The ability of tumor necrosis factor-alpha (TNF-alpha) to prime the oxidative burst was also assessed. Phagocytosis of Staphylococcus aureus and basal H2O2 and O2- release by PMN did not differ between normal subjects and patients with chronic renal insufficiency. However, the oxidative burst stimulated by S. aureus and formyl-Met-Leu-Phe, but not phorbol myristate acetate, was significantly enhanced in PMN from patients with chronic renal insufficiency. The increase in formyl-Met-Leu-Phe-stimulated oxidative burst correlated significantly with the level of renal function. TNF-alpha significantly increased S. aureus-induced H2O2 production in normal PMN, but not in PMN from patients with chronic renal insufficiency. These data indicate that chronic renal insufficiency does not impair PMN phagocytosis and oxidative burst. To the contrary, it enhances receptor-mediated oxidative burst. The inability of TNF-alpha to further enhance the oxidative burst suggests that PMN exist in a primed state in patients with chronic renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780059     DOI: 10.1681/ASN.V591697

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  10 in total

1.  Inhibition of human lymphocyte function by organic solvents.

Authors:  A S Shoker; M A Murabit; F F Georges; L F Qualtiere; H G Deneer; K Prasad
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

2.  Effects of hemodialysis period on levels of blood trace elements and oxidative stress.

Authors:  Tulay Koca; Asiye Berber; Halit Bugra Koca; Temir A Demir; Tulay Koken
Journal:  Clin Exp Nephrol       Date:  2010-06-30       Impact factor: 2.801

3.  Interleukin-10 versus dexamethasone: effects on polymorphonuclear leukocyte functions of the newborn.

Authors:  Brett V Citarella; Veronika Miskolci; Ivana Vancurova; Dennis Davidson
Journal:  Pediatr Res       Date:  2009-04       Impact factor: 3.756

Review 4.  Oxidative stress in chronic kidney disease.

Authors:  Kristien Daenen; Asmin Andries; Djalila Mekahli; Ann Van Schepdael; François Jouret; Bert Bammens
Journal:  Pediatr Nephrol       Date:  2018-08-13       Impact factor: 3.714

Review 5.  Cardiorenal Syndrome and Heart Failure-Challenges and Opportunities.

Authors:  Haran Yogasundaram; Mark C Chappell; Branko Braam; Gavin Y Oudit
Journal:  Can J Cardiol       Date:  2019-04-12       Impact factor: 6.614

6.  NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.

Authors:  Simona Granata; Valentina Masola; Elisa Zoratti; Maria Teresa Scupoli; Anna Baruzzi; Michele Messa; Fabio Sallustio; Loreto Gesualdo; Antonio Lupo; Gianluigi Zaza
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 7.  Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach.

Authors:  Caroline Lamarche; Ioan-Andrei Iliuta; Thomas Kitzler
Journal:  Can J Kidney Health Dis       Date:  2019-04-29

Review 8.  The role of neuroimmune and inflammation in pediatric uremia-induced neuropathy.

Authors:  Linfeng Zhu; Guoqin Tong; Fan Yang; Yijun Zhao; Guangjie Chen
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

9.  Total and corrected antioxidant capacity in hemodialyzed patients.

Authors:  Niki Malliaraki; Dimitris Mpliamplias; Marilena Kampa; Kostas Perakis; Andrew N Margioris; Elias Castanas
Journal:  BMC Nephrol       Date:  2003-07-01       Impact factor: 2.388

10.  Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.

Authors:  Sandra Lemesch; Werner Ribitsch; Gernot Schilcher; Walter Spindelböck; Hildegard Hafner-Gießauf; Gunther Marsche; Lisa Pasterk; Doris Payerl; Bianca Schmerböck; Monika Tawdrous; Alexander R Rosenkranz; Philipp Stiegler; Gerd Kager; Seth Hallström; Karl Oettl; Katharina Eberhard; Angela Horvath; Bettina Leber; Vanessa Stadlbauer
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.